ischemic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: According to the characteristics of coronary heart disease and clinical diagnosis and treatment in China, 1500 patients with coronary heart disease, 1500 patients with coronary heart disease after PCI and 1500 patients with coronary heart disease after coronary artery bypass grafting are proposed to be included. The patients are distributed in the eastern and western regions of China, coastal and inland cities, including the ages under 40, 40-60 and over 60 Layer. Patients with diabetes and renal insufficiency should be studied as a subgroup.
Exclusion criteria
Exclusion criteria: Patients with systemic active infection; patients with severe hepatorenal insufficiency (ALT > 135mmol / L, Cr > 200umol / L) or chronic obstructive pulmonary disease; patients with obvious bleeding tendency and hematologic diseases; patients with malignant tumors and end-stage diseases; patients with life expectancy less than 6 months; patients with heart valve or left ventricular aneurysm and other diseases requiring simultaneous operation; patients with cerebrovascular diseases (at present or within six months, there has been cerebral infarction or cerebral hemorrhage); recently participated in the trial drug research but failed to complete the main end point or clinically hindered the clinical research end point.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thromboembolic events;Bleeding events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulse wave detection;24 channel bioelectrical impedance measurement;Coagulation and platelet function; | — |
Countries
China
Contacts
Cardiovascular Surgery, the First Medical Center, General Hospital of the People's Liberation Army of China